The estimated Net Worth of Matthew Bennett Arnold is at least $25.8 Milion dollars as of 14 January 2019. Mr. Arnold owns over 5,000 units of Solid Biosciences Inc stock worth over $25,363,335 and over the last 6 years he sold SLDB stock worth over $310,400. In addition, he makes $82,465 as Independent Director at Solid Biosciences Inc.
Sign up
Mr. Arnold SLDB stock SEC Form 4 insiders trading
Matthew has made over 2 trades of the Solid Biosciences Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 5,000 units of SLDB stock worth $160,000 on 14 January 2019.
The largest trade he's ever made was selling 5,000 units of Solid Biosciences Inc stock on 14 January 2019 worth over $160,000. On average, Matthew trades about 1,111 units every 1 days since 2018. As of 14 January 2019 he still owns at least 3,386,293 units of Solid Biosciences Inc stock.
You can see the complete history of Mr. Arnold stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Matthew Arnold biography
Matthew Arnold is an Independent Director of the Company. He is a founding member of Solid and has served as a member of our board of directors since our inception in 2013. A former energy executive, since 2009, Mr. Arnold has been actively working with startup businesses in the United Kingdom and Europe, primarily in the technology and clean tech sectors. He holds an M.S. from the University of Virginia and a B.A. from Duke University. Mr. Arnold is qualified to serve on our board of directors because of his extensive management and board experience with startup companies and his background in finance.
What is the salary of Matthew Arnold?
As the Independent Director of Solid Biosciences Inc, the total compensation of Matthew Arnold at Solid Biosciences Inc is $82,465. There are 10 executives at Solid Biosciences Inc getting paid more, with Carl Morris having the highest compensation of $4,052,210.
How old is Matthew Arnold?
Matthew Arnold is 50, he's been the Independent Director of Solid Biosciences Inc since . There are 10 older and 8 younger executives at Solid Biosciences Inc. The oldest executive at Solid Biosciences Inc is Stephen J. DiPalma M.B.A., 62, who is the Treasurer & Principal Accounting Officer.
What's Matthew Arnold's mailing address?
Matthew's mailing address filed with the SEC is 5th, 141 Portland St, Cambridge, MA 02139, USA.
Insiders trading at Solid Biosciences Inc
Over the last 7 years, insiders at Solid Biosciences Inc have traded over $9,620,465 worth of Solid Biosciences Inc stock and bought 13,973,934 units worth $97,227,521 . The most active insiders traders include Advisors Llcperceptive Life..., Capital Management, L.P.Ra ... a Rajeev M. Shah. On average, Solid Biosciences Inc executives and independent directors trade stock every 38 days with the average trade being worth of $1,822,871. The most recent stock trade was executed by Ian F Smith on 3 July 2024, trading 3,255 units of SLDB stock currently worth $24,380.
What does Solid Biosciences Inc do?
solid biosciences (solid) is a cambridge, ma based biotech company singularly focused on developing treatments and cures for duchenne muscular dystrophy (dmd). solid combines sharp commercial focus with world-class science to advance promising therapies and is positioned to catalyze therapeutic development across all aspects of the disease. condition-focused, our mandate is comprehensive; improving daily life for patients and attacking the roots of dmd.
What does Solid Biosciences Inc's logo look like?
Complete history of Mr. Arnold stock trades at Solid Biosciences Inc
Solid Biosciences Inc executives and stock owners
Solid Biosciences Inc executives and other stock owners filed with the SEC include:
-
Carl Morris,
Chief Scientific Officer -
Ilan Ganot,
President, Chief Executive Officer, Co-Founder, Director -
Jennifer Ziolkowski,
Chief Financial Officer, Treasurer -
Ilan Ganot,
Co-founder, Pres, CEO & Director -
Dr. Carl Ashley Morris,
Chief Scientific Officer -
Adam Koppel,
Independent Director -
Lynne Sullivan,
Independent Director -
Martin Freed,
Independent Director -
Dr. Andrey Juan Zarur Ph.D.,
Co-Founder -
Adam Stone,
Independent Director -
Sukumar Nagendran,
Independent Director -
Matthew Arnold,
Independent Director -
Rajeev Shah,
Independent Director -
Robert Huffines,
Independent Director -
Ian F. Smith A.C.A., ACA, C.P.A., CPA,
Exec. Chair -
Matthew Bennett Arnold,
Co-Founder & Board Member -
Carlo Tanzi,
IR Contact Officer -
Lynette Herscha,
Chief Legal Officer and Secretary -
Joel Schneider,
Chief Technology Officer and Head of Exploratory Research and Development -
Ian Smith,
Chairman of the Board -
Gilad David Hayeem,
Co-Founder -
Dr. Cathryn M. Clary M.B.A., M.D.,
Acting Chief Medical Officer -
Erin Powers Brennan,
Chief Legal Officer & Sec. -
Caitlin Lowie,
VP of Communications & IR -
Stephen J. DiPalma M.B.A.,
Treasurer & Principal Accounting Officer -
Dr. Joel Solomon Zev Schneider Ph.D.,
Chief Operating Officer -
Michael Inbar CPA, M.B.A.,
Sr. VP of Fin. -
Annie Ganot,
Co-Founder & Director of Patient Advocacy -
Pedro Alvaro Amorrortu,
Chief Operating Officer -
Jorge Armando Quiroz,
Chief Medical Officer -
Capital Management, L.P.Ra ...,
-
Advisors Llcperceptive Life...,
-
Chase & Cojpmc Strategic In...,
-
Advisors Llcedelman Joseph ...,
-
Gilad David Hayeem,
10% owner -
Juan Andrey Zarur,
Director -
Kevin Tan,
CFO & Treasurer -
Capital, Llc Boxer,
10% owner -
Capital Management, L.P.Ra ...,
-
Capital Life Sciences Inves...,
-
Advisors Llcperceptive Life...,
-
Capital Management, L.P.Ra ...,
-
Jessie Hanrahan,
Chief Regulatory Officer -
Erin Powers Brennan,
Chief Legal Officer, Secretary -
Clare Kahn,
-
Advisors Llcperceptive Life...,
-
David T Howton,
Chief Operating Officer -
Jennifer Marlowe,
CSO -
Alexander Cumbo,
President and CEO -
Paul Herzich,
Chief Technology Officer -
Gabriel Brooks,
Chief Medical Officer -
Georgia Keresty,